Abstract
In this study, we evaluated the impact of human gut microbiota on the immune pathways in the respiratory tract using a gnotobiotic (Gn) piglet model. We humanized piglets with rural and urban infant fecal microbiota (RIFM and UIFM, respectively) and then infected them with a H1N1 swine influenza virus. We analyzed the microbial diversity and structure of the intestinal and respiratory tracts of the piglets before and after the influenza virus infection and measured the viral load and immune responses. We found that the viral load in the upper respiratory tract of UIFM transplanted piglets was higher than their rural cohorts (RIFM), while virus-specific antibody responses were comparable. The relative cytokine gene expression in the tracheobronchial (respiratory tract) and mesenteric (gastrointestinal) lymph nodes, lungs, blood, and spleen of RIFM and UIFM piglets revealed a trend in reciprocal regulation of proinflammatory, innate, and adaptive immune-associated cytokines as well as the frequency of T-helper/memory cells, cytotoxic T cells, and myeloid immune cell subsets. We also observed different phylum-level shifts of the fecal microbiota in response to influenza virus infection between the two piglet groups, suggesting the potential impact of the gut microbiota on the immune responses to influenza virus infection and lung microbiota. In conclusion, Gn piglets humanized with diverse infant fecal microbiota had differential immune regulation, with UIFM favoring the activation of proinflammatory immune mediators following an influenza virus infection compared to their rural RIFM cohorts. Furthermore, Gn piglets can be a useful model in investigating the impact of diverse human microbiota of the gastrointestinal tract, probably also the respiratory tract, on respiratory health and testing specific probiotic- or prebiotic-based therapeutics.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Annual epidemics of influenza result in 3 to 5 million cases of severe illness and 290,000 to 650,000 deaths globally [1]. Strikingly, about 99% of the deaths occur in children under the age of two years with serious health complications due to influenza [2]. Dysbiosis of the microbiota of the upper respiratory tract was reported in children with influenza A virus infection [3]. The gut microbiota plays an important role in maintaining immune homeostasis and good health and can influence the outcome of infections [4]. The types of microorganisms colonizing in infants during the first year of life can profoundly impact the outcome of immune responses for the rest of their life [5]. The diverse commensal microbes influence the immune development and function of the mucosal immune system and inhibit the colonization of pathogenic organisms [6]. Influenza is a disease of humans and some species of mammals and birds globally [7]. Humans and piglets are the natural hosts of influenza causing similar acute respiratory diseases mediated by secreting inflammatory mediators, causing fever, body aches, and fatigue [8, 9]. Recent research has been focusing on gut microbiota transplantation therapy to mitigate the severity of influenza, due to the low to moderate efficacy of seasonal influenza vaccines against disease and virus transmission [10]. Studies have revealed that a diverse and healthy commensal gut microbiome activates the innate immune pathways mediated via Toll-like receptors [11] and protects the host against influenza virus infection [12]. The nose/throat microbiota diversity before influenza virus infection is associated with influenza symptoms and duration of virus shedding in the host [13].
The diversity of intestinal microbiota is attributed mainly to a host of factors including the environment where people live, and gut microbes constantly interact with host immune cells. Gut microbes and their metabolites influence not only the health of the gut but also the respiratory tract [14,15,16]. Rural children have a lower prevalence of asthma and allergic sensitization by four- to six-fold than their urban cohorts, attributed to early life exposure to diverse allergens, microbes, and endotoxins, which have a profound influence on building the healthy immune system [17]. Studies using a mouse model provide crucial insights into the mechanism(s) regulating the immune systems mediated by the gut microbiota [18, 19]. However, the applicability of the microbiota-induced immune response in mice to humans for translational studies is questionable [20]. Thus, to understand the role of gut bacterial species and their diversity on respiratory tract immune profiles, a suitable large animal model that closely mimics the growth and colonization of most human gut bacteria is essential [21].
Swine are considered an appropriate animal model for influenza research over rodents because, unlike mice, pigs are a natural host for influenza as humans, and their anatomical, immunological, physiological, and genetic compositions are comparable to humans [22,23,24]. Comparison between gnotobiotic pig and mouse for immune and microbiome research is provided in a table (Supplementary Table S1). We demonstrated in a previous study that gnotobiotic (Gn) piglets humanized with rural and urban infant human fecal microbiota (RIFM and UIFM) harbored microbial diversity and composition comparable to the original IFM inoculum and differentially modulated the mucosal immune development [21]. In the present study, we humanized Gn piglets with RIFM and UIFM collected in that study [21] and further examined how the two types of diverse fecal microbiota modulate immune responses to influenza virus infection, and whether immune pathways correlate to specific groups of microbes in the host.
Materials and Methods
Fecal Microbiota Sample Collection
The details of collection of fecal samples from healthy infants from Amish (rural) and non-Amish (urban) families in accordance with the sampling protocol approved by The Ohio State University Institutional Review Board (IRB#2015H3281) were provided in our previous study [21]. We used five each of apparently healthy infants from rural and urban families. The Amish families had farm animals (cattle, sheep and/or horses) and pets (dog and/or cat), while the non-Amish households were from families located in the Wooster city limits with no contact with livestock but had pets. For this study, infants who were born through natural vaginal delivery were enrolled. Fecal samples were collected from fresh soiled diapers as described previously [21, 25, 26]. Briefly, the parents placed the fecal material in a tube containing glass bead for homogenization, then filled the tube with sterile anaerobic media. Tubes were kept on ice and immediately transported to the lab. Inside of an anaerobic chamber, the sample was homogenized vigorously, 15% sterilized glycerol was added, and 1 mL aliquots were prepared and stored at −80 °C.
Fecal Microbiota Humanization and Influenza Virus Infection of Gn Piglets and Sample Collection
A healthy pregnant sow (gestation day 105) procured from The Ohio State University swine herd was kept in our swine isolation facility for one week rest period. Gn piglets were delivered by cesarean section as described previously [27]. Piglets were kept and cared in individual temperature-controlled sterile Gn isolators and fed with sterile infant milk formula as described [21]. The male and female piglets were randomly allocated into two groups (n = 4 or 5 per group). Rural and urban fecal microbial inocula were prepared freshly by pooling five each of Amish (rural) infant fecal microbiota (RIFM) aliquots (1.0 mL each) and the other being a mixture of the five non-Amish (urban) infant fecal microbiota (UIFM) aliquots. The pooling of the microbiota took place inside an anaerobic chamber to maintain anaerobiosis. Each fecal inoculum was mixed with a 50 ml sterile infant milk formula and delivered orally once to individual piglets of each group at 8 days of age. An exactly similar procedure and same pooled five infants RIFM and UIFM were used in an earlier pig transplantation study for microbial and immune analysis [21]. Due to limited space to handle many pigs in our germ-free isolators, we did not use those groups again as controls in this study.
Gut microbiota-humanized piglets were infected with a swine influenza virus H1N1 (A/Swine/OH/24366/2007) [21, 28] by inoculation of 2 × 107 TCID50 (tissue culture infectious dose) virus in 1 mL as intranasal drops at 41 days of age (33 days post-fecal inoculation). Piglets were monitored twice daily for clinical influenza signs (fever, lethargy, anorexia, and labored breathing). Nasal and fecal swab samples were collected at days post-viral infection (DPI) 0, 2, 4 and 7 for microbiota analysis and to determine the viral load. On the day of necropsy (DPI7), piglets were given a sedative, TKX (telazol, xylazine, and ketamine), and blood was collected for isolating peripheral blood mononuclear cells (PBMCs) and euthanized by injecting sodium pentobarbital by intracardiac route into the heart. We collected bronchoalveolar lavage (BAL) fluid, tracheobronchial lymph nodes (TBLN), and mesenteric lymph nodes (MLN) for isolating mononuclear cells (MNCs) as described earlier [29]. Spleen, lung, TBLN, and MLN tissue samples were collected in RNAlater for the analysis of cytokine gene expression. Nasal wash, BAL fluid, ileum, and colon contents were used for microbiota analysis (Fig. 1). In this study, we did not include some of the control groups such as a group treated with IFM but no influenza infection and a group that was not infected or treated with IFM, because using the same infant fecal material we performed the detailed analysis including those groups for colonized microbiota species in a previous study in 2019 [21].
Determining the Influenza Virus Load in the Respiratory Tract
Estimation of the replicating virus load was performed by cell culture method as described previously [29]. Briefly, tenfold diluted nasal swab fluid and BAL fluid samples were subjected to virus titration using madin-darby canine kidney epithelial (MDCK) cells incubated for 48 h at 37 °C in 5% CO2 incubator. Cells were immunostained with influenza virus nucleoprotein-specific primary antibody (CalBioreagents, CA) followed by treatment with the secondary antibody AlexaFluor 488-conjugated goat anti-mouse IgG (H + L) (Life technologies, CA). The green fluorescence signals were read under a fluorescent microscope and virus titers were calculated in 50% TCID50/ml as described previously [29].
Influenza Virus-Specific Antibody Analysis
The swine influenza virus H1N1-specific IgG and IgA antibodies in serum, BAL fluid, and nasal swab samples were determined by ELISA as described previously [30]. Briefly, 96-well plates were coated with pretitrated killed virus antigens overnight (10 μg/mL) and blocked with 5% skim milk powder containing 0.05% Tween-20. Plates were washed and then diluted test samples in PBS containing 2.5% skim milk powder and Tween-20 were added to marked duplicate wells, incubated for 2 h at room temperature (RT), washed, and secondary antibody horse radish peroxidase-conjugated goat anti-pig IgG (KPL, MD, USA) or goat anti-pig IgA (Bethyl laboratories Inc., TX, USA) was added. The antigen and antibody interactions were detected by using 1:1 mixture of peroxidase substrate solution B and TMB peroxidase substrate (KPL, MD, USA). The reaction was stopped by adding 1.0 M phosphoric acid after 10 min of incubation, and optical density was measured at 450 nm using a Spectramax microplate reader (Molecular devices, CA, USA).
Flow Cytometry Analysis
PBMCs, BAL cells, and TBLN and MLN MNCs were immunostained to determine the frequency of cytotoxic T lymphocytes (CTLs) (CD3+CD4−CD8α+β+), T-helper/memory cells (CD3+CD4+CD8α+β−), and myeloid cells (CD3− non-T cells and CD3−CD172a+ cells) using specific immune markers and analyzed as described earlier [21, 29, 31]. The cells were fixed and 100,000 events were acquired (BD Aria II flow cytometer, BD Biosciences, CA) and the data were analyzed using FlowJo software (Tree Star, Palo Alto, CA). The specific anti-pig and their respective isotype control monoclonal antibodies used for immunostaining lymphocytes and myeloid cells were either purified, biotin or fluorochrome labeled, that include CD3 (Southern biotech, AL), CD4α, CD8α, monocyte/granulocyte CD172a (Southern biotech, AL), and CD8β chain (BD Pharmingen, CA) followed by the addition of anti-isotype-specific secondary antibody or streptavidin fluorochrome.
Quantitative Reverse Transcription PCR (RT-qPCR) Analysis for Immune Gene Expression
Total RNA was extracted from samples using the Trizol reagent (Invitrogen, Carlsbad, CA, USA) by following the manufacturer's protocol. The integrity and purity of the extracted RNA were assessed via spectrophotometry (NanoDrop 2000, Thermo Fisher Scientific, Waltham, MA, USA), ensuring the A260/A280 ratio was between 1.8 and 2.1. To remove any potential DNA contamination, RNA samples were treated with DNase I (Sigma-Aldrich, St. Louis, MO, USA).
Quantitative real-time PCR was conducted using the SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA) on a One-Step Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). Each 20 µL reaction mixture included 10 µL of SYBR Green Master Mix, 1 µL of each primer (10 µM), 2 µL of cDNA, and 6 µL of nuclease-free water. The sequence details of primers used are provided (Supplementary Table S2). The thermal cycling conditions were as follows: initial denaturation at 95 °C for 10 min, followed by 40 cycles of denaturation at 95 °C for 15 s, and annealing/extension at 60 °C for 1 min. Relative expression levels of the target genes were calculated using the 2 − ΔΔCT method, with β-actin serving as the reference gene as described previously [30, 32,33,34].
Metataxonomic Analyses of Microbiota
Metagenomic DNA extraction, amplicon library preparation (the V3-V4 regions of the 16S rRNA gene), paired-end sequencing (2 × 300 bp), and subsequent sequence data processing and analyses were the same as described in a previous study [21]. Briefly, with QIIME2 (version 2021.4) [35], the amplicon sequencing reads were demultiplexed, trimmed off the adapter and primers, quality filtered (Q-score ≥ 25), denoised, and merged using the DADA2 plugin [36]. After removing chimeric sequences, DADA2 clustered the sequences into amplicon sequence variants (ASVs) and generated the ASV feature table. The naive Bayes classifier was trained against the targeted region (V3-V4) of the SILVA database (release v138) [37] and then used to taxonomically assign the ASVs. The alpha- and beta-diversity were analyzed using the Phyloseq package [38] in R [39], with the number of ASVs rarefied to 4,000 per sample for alpha-diversity analysis.
Statistical Analysis
For the immune response data, statistical comparisons were made between RIFM and UIFM humanized piglet groups (i.e., RIFMP and UIFMP) for each designated time point, sample type, and type of experiment throughout the study unless specified otherwise by using JMP Pro 15 (SAS; Cary, NC), GraphPad Prism 9.5 (San Diego, CA), and RStudio (Boston, CA). The virus titer, antibody levels, cytokine mRNA expression, and flow cytometry data were analyzed by using non-parametric Mann–Whitney test. The data were presented as the mean ± SEM of each piglet group. Significance was declared at P < 0.05. Asterisks denote significant difference (*P < 0.05, **P < 0.01, and ***P < 0.001).
For the microbiota data, Shannon diversity index values were compared between RIFMP and UIFMP at each time point with the Wilcoxon rank sum test. The two piglet groups were compared for their overall microbiota at each time point with principal coordinates analysis (PCoA) based on Bray–Curtis dissimilarities, and significance of difference was tested with permutational multivariate analysis of variance (PERMONAVA) in R using the adonis function of the vegan package [40] in R with 999 permutations. The ASVs with a relative abundance of less than 0.01% and detected in less than 10% of the piglets were filtered out and then the major ASVs were collapsed into genera. Differentially abundant genera between the two piglet groups and before and after the influenza virus infection were analyzed with ANCOM-BC with the following settings: zero_cut = 0.70, lib_cut = 0, struc_zero = TRUE, neg_lb = TRUE, tol = 1e-5, max_iter = 100, conserve = TRUE, and alpha = 0.05. The P-values were corrected for multiple comparison with the Holm–Bonferroni method, and an adjusted P-value < 0.05 was considered significant. Kendall’s rank correlation was used to determine the association of the relative abundance of bacterial genera with immune cell counts and the expression of cytokines. The correlation results were visualized with the ComplexHeatmap package in R [41].
Results
The Diverse Infant Microbiota Influences the Influenza Virus Load in the Upper Respiratory Tract But Not the Antibody Responses in IFM Humanized Piglets.
The RIFM and UIFM humanized Gn piglets (RIFMP and UIFMP) were allowed to colonize with the IFM microbes for 33 days before being infected with a zoonotic swine influenza virus. Some of the UIFMP had mild fever (above 103°F) and none of their RIFMP cohorts had any fever. However, we did not observe any visible influenza-associated clinical signs in any of the piglets. This is consistent with earlier studies in which pigs aged 10–12 weeks infected with the same H1N1 viral strain only by intranasal route did not cause apparent disease, while infection by both intranasal and intratracheal routes induced influenza signs and fever for 3–4 days including lung inflammation [29, 42]. The replicating infectious virus titers were measured in the nasal swab samples at various DPI and in BAL fluid at DPI 7. The virus was detectable at DPI 2 and 4, but not at DPI 7 in nasal swab and in BAL fluid. In UIFMP group, we detected higher viral titers at both DPI 2 and 4 than their RIFMP cohorts (Fig. 2i a, b and data not shown). However, influenza virus-specific systemic IgG and BAL and nasal IgA antibody responses were comparable in both the RIFMP and the UIFMP groups (Fig. 2i c, d, e).
Both the Diverse Microbiota and Influenza Virus Infection Modulate Lymphoid and Myeloid Immune Cell Populations in Piglets.
The immune cells isolated from piglets were immunostained using specific anti-pig cell surface markers to identify the frequencies of lymphoid and myeloid cell subsets. We followed the standard cell gating strategy to delineate the cytotoxic T lymphocytes (CTLs), T-helper/memory cells and two myeloid cell subsets, and a schematic showing how the immune cells were gated for different phenotypic markers is presented [Supplementary Fig. S1). The two piglet groups had differential activation of immune cells in terms of relative abundance of CTLs and T-helper/memory cells in TBLN, MLN, and PBMCs [Fig. 2ii]. Particularly, T-helper/memory cells frequency tended to increase in UIFMP compared to their cohort RIFMP (Fig. 2ii a, b, c). The frequency of non-T cells (CD3−) and myeloid cells (CD3−CD172a) in the mucosal lymph nodes (TBLN and MLN), lungs, and blood was delineated [Fig. 2iii]. We observed an increased trend in the frequency of non-T cells (myeloid cells CD3−) in MLN and CD172a+ myeloid cells in PBMCs and a numerical decrease in TBLN and BAL cells (Fig. 2iii a, b, c, and d).
Cytokine Gene Expression is Differentially Modulated in the Mucosal Tissues of Diverse IFM-Colonized Piglets.
In TBLN of RIFMP compared to UIFMP group, we observed an increased trend in the expression of cytokines mRNA IL-2, IL-4, and IL-10, reduced trend in IL-12, and the comparable expression levels of IL-6 and IFNγ (Fig. 3a–f). In MLN of RIFMP compared to UIFMP group, we observed an increased trend in the expression of cytokines mRNA IL-2 and IL-4, reduced trend in IL-6 and IFNγ, and comparable levels of IL-10 and IL-12 expressions (Fig. 3g–l). In the lungs of RIFMP compared to UIFMP group, we observed an increased trend in the expression of mRNA of cytokines IL-2 and IL-4, reduced trend in IL-12 and IL-6 (significant P < 0.05), and comparable levels of IFNγ expression (Fig. 3m–r). In spleen of RIFMP compared to UIFMP group, we observed a reduced trend in the expression levels of cytokine mRNA IL-2, significantly (P < 0.05) increased IL-6, and comparable levels in the expression of IL-4, IL-10 IL-12 and IFNγ cytokines (Fig. 3s–x).
Influenza Virus Infection Differently Affects the Fecal, Intestinal, and Respiratory Tract Microbiotas in RIFM vs. UIFM Piglets.
Shannon–Wiener diversity index of the fecal microbiota did not differ between the two piglet groups (RIFMP vs. UIFMP), or before and after the viral infection (Fig. S5), corroborating the observation of our previous study [21]. The overall fecal microbiota did not differ between RIFMP and UIFMP at day 22 but differed at day 40 (day of viral infection, prior to infection) and day 42 (2 days post-viral infection), and then converged at day 47 (7 days post-viral infection) (Fig. S2). This is consistent with our previous study in which significant difference in overall fecal microbiota was not observed until 5 weeks post-IFM humanization [21]. We acknowledge the small sample size that might have prevented robust microbiota comparison between the two groups of piglets.
Some individual bacterial taxa appeared to differ in relative abundance between the two piglet groups and responded differently to the viral infection. Bacteroidetes, Firmicutes, and Proteobacteria are the major phyla and Actinobacteria and Verrucomicrobia are the minor phyla of bacteria detected in the fecal samples over the course of the experiment (Fig. S3A). The two groups of piglets differed in relative abundance of the above bacterial phyla both before and after the influenza virus infection. At day 22, the rural group had a significantly higher relative abundance of Proteobacteria than in the urban group, while the opposite was true for Bacteroidetes, Firmicutes, and Verrucomicrobia. By day 40 (the same day of, but post, influenza virus infection), Firmicutes and Bacteroidetes gained abundance at the expense of Proteobacteria in the rural group, while in the urban group, only Firmicutes gained abundance at the expense of Bacteroidetes and Verrucomicrobia.
The response of fecal microbiota to influenza virus infection was evaluated at the genus level. The genera Clostridium, Dorea, Klebsiella, and Streptococcus and one unclassified genus of the family Mogibacteriaceae were found to be significantly more abundant in the urban than in the rural groups after the viral infection (Fig. S6).
The nasal microbiota also differed between the two piglet groups and underwent different shifts at the phylum level (Fig. S3B). Notably, on day 40 (day of viral infection, prior to infection), the rural group had more Bacteroidetes but less Actinobacteria and Proteobacteria than the urban group. Interestingly, by day 42 (2 days post-influenza virus infection), Firmicutes became the overwhelmingly dominant phylum in both piglet groups, with the rural group still having less Actinobacteria and Proteobacteria. Four days following viral infection, the rural group had little phylum-level shift, but the urban group had increased Proteobacteria and Actinobacteria but decreased Firmicutes. By the end of the experiment, 7 days post-influenza virus infection, the phylum-level profiles of the nasal microbiota in both groups mostly recovered, except for decreased Proteobacteria and detection of bacteria that could not be classified to any known phyla. Similar to the fecal microbiota, the nasal microbiota of the two piglet groups underwent different phylum-level shifts after influenza virus infection, which might reflect a difference in the nasal microbiota. It should be noted that the Gn piglets were humanized with infant fecal microbiota, but not nasal microbiota. Thus, their respiratory tract could only be colonized with bacteria from the fecal microbiota and the respiratory microbiota probably differed from that typically found in piglets.
At the end of the experiment, which was 7 days after the viral infection, when piglets were euthanized, colon, ileum, and bronchoalveolar lavage fluid were sampled for microbiota analysis. The rural group had more Proteobacteria but less Firmicutes in the lung than the urban group (Fig. S3C). In the colon, the rural group had more Bacteroidetes and Firmicutes but less Proteobacteria and Verrucomicrobia than the urban group. The two piglet groups had similar ileal phylum-level profiles. Without a control group that was not infected with influenza virus, we could not determine if the two piglet groups had different microbiota in their lung and intestines before influenza virus infection and how influenza virus infection might have caused different alterations of the lung and intestinal microbiota. However, the different phylum-level shifts of the fecal microbiota in response to influenza virus infection between the two piglet groups may also suggest different microbiota alterations in the lung and intestines. In addition, a longitudinal distribution of relative abundance of bacterial phyla detected in nasal passage at day 20 to 47, and day 47 in lungs, ilium, and colon is shown (Fig. S4).
Some Bacteria in the Feces and Colon Content Correlate with Immune Cells and Immunoglobins.
The abundance of some genera of colonic bacteria (7 days post-influenza virus infection) and fecal microbiota (7 days post-influenza virus infection) correlated with the frequency/population of different immune cells (Fig. 4a). In the colonic microbiota, Enterococcus negatively correlated with T-helper/memory cell population, while Citrobacter and Turicibacter negatively correlated with myeloid cell population. Non-T-cell frequency correlated with different genera, including positive correlation with Morganella but negative correlation with Pseudoramibacter, Shigella, and one unclassified genus of Clostridiales. More genera of the fecal microbiota correlated with immune cells: Myeloid cell counts positively correlated with Streptococcus, Parabacteroides, Enterococcus, Odoribacter, Eubacterium, Butyricimonas, and one unclassified genus of Morgibacteriaceae, but negatively correlated with Citrobacter and Turicibacter. Twelve genera of fecal bacteria had correlations with non-T-cell population, including a positive correlation with Streptococcus, Parabacteroides, and Enterococcus, and a negative correlation with genera such as Sutterella and Ruminococcus, and six other genera each of RF32 and Barnesiellaceae. Cytotoxic T-cell frequency also appeared correlated with some genera of fecal bacteria, including a negative correlation with Streptococcus, Parabacteroides, Enterococcus, and Corynebacterium, and a positive correlation with Shigella and Citrobacter. Furthermore, T-helper/memory cell population positively correlated with fecal Peptococcus, Proteus, Robinsoniella, and one unclassified genus of Peptostreptococcaceae and negatively correlated with fecal Bifidobacterium, Slackia, Blautia, Collinsella, Allobaculum, and one unclassified genus each in the families of Christensenellaceae and Barnesiellaceae. The relative abundance of some bacterial genera in bronchoalveolar lavage fluid correlated with the BAL fluid IgG and IgA titers, BAL fluid immune cell counts, TBLN MINCs immune cell counts, and myeloid cell counts (Fig. 4b).
Specifically, the relative abundance of Chryseobacterium positively correlated with the titers of both BAL fluid IgG and IgA titers, while that of Moreaxella negatively correlated with the titer of only BAL fluid IgG. Non-T-cell (CD3-) population in BAL fluid positively correlated with Anaerotruncus and one unclassified genus of Sinobacteraceae, while the BAL fluid myeloid cell population positively correlated with Pseudomonas, Bosea, Sediminibacterium, Mesorhizobium, and one unclassified genus of Bradyrhizobiaceae, but negatively correlated with Bifidobacterium, Lactobacillus, Ruminococcus, one unclassified genus each of the class Clostridiales and the candidate family RF32. With respect to TBLN MNCs immune cells, T-helper/memory cell population negatively correlated with Methylobacterium, Bergeyella, and one unclassified genus of Phyllobacteriaceae, while the cytotoxic T-cell frequency had a positive correlation with Blautia and Oscillospira but a negative correlation with Burkholderia, Faecalibacterium, Proteus, Peptoniphilus, and Klebsiella. In the TBLN MNCs, we found myeloid cells, non-T cells (CD3-) positively correlated with Anaerotruncus, while myeloid cells negatively correlated with Eggerthella, Staphylococcus, and Bergeyella.
In the TBLN, IL-2 expression correlated with the most genera of bronchoalveolar lavage fluid bacteria, including positive correlation with Mesorhizobium, Sediminibacterium, Brevundimonas, Bosea, Dokdonella, and Ochrobactrum and negative correlation with Bifidobacterium, Enterococcus, Bacteroides, Klebsiella, Phascolarctobacterium, and Streptococcus (Fig. 5a). The spleen IFNγ correlated with the second most genera of bronchoalveolar lavage fluid bacteria, including a positive correlation with Mesorhizobium, Brevundimonas, Phyllobacterium, Shigella, and Staphylococcus and a negative correlation with Lactobacillus, Bilophila, Alistipes, and Phascolarctobacterium. Interestingly, several genera of bronchoalveolar lavage fluid were correlated with the expression of two or more different cytokines, including Mesorhizobium, Sediminibacterium, Brevundimonas, Phyllobacterium, Staphylococcus, Dorea. Burkholderia, Lactobacillus, Alistipes, and Streptococcus.
A total of 22 genera and 13 unclassified or candidate genera of fecal and intestinal (ileal and colonic) bacteria correlated positively and/or negatively with the expression of one or more cytokines (Fig. 5b). More genera of the colonic bacteria had a correlation, mostly positive correlation, with the cytokine expression than the ileal or fecal bacteria. Notably, in the MLN, IL-2 expression correlated positively with Holdemania, Slackia, Shigella, and Alistipes and several unclassified genera, while in MLN IL-4, the expression was positively correlated with Collinsella, Desulfovibrio, Allobaculum, Ruminococcus, Oscillospira, Blautia, and Bacteroides. The expression of IL-6 in the spleen also correlated with numerous genera of bacteria, including a negative correlation with Peptococcus, and a positive correlation with Odoribacter, Alistipes, Anaerotruncus, Collinesella, and three unclassified genera.
Discussion
Changes in intestinal bacterial structure can influence disease outcomes in the respiratory tract away from the gut. It has been suggested that gut microbiota can modulate the antiviral immune responses, potentially mediated by metabolites like short-chain fatty acids [43]. In addition, mononuclear phagocytes in the intestine and respiratory tract can sample antigens in the lumen and activate adaptive immunity to promote the clearance of viruses and other pathogens [43]. Our data suggest that infant microbiota likely influences the influenza virus load in the respiratory tract, mediated by differentially modulated innate and Th1 immune-inducing factors but not Th2 factors, because antibody responses in IFM humanized piglets were not altered.
The CD172a is expressed on all the pig monocytes, granulocytes, and dendritic cells but not on T and B cells [44, 45]. The commensal microbiota composition critically regulates the generation of virus-specific CD4 and CD8 T cells and antibody responses following influenza virus infection [11].
The interplay between the gastrointestinal microbiota, invasive viruses, and host immunology is complex and not fully characterized; however, recent evidence shows that the microbiota plays an important role in the pathogenesis of viral diseases [46]. The gut microbiota provides necessary signals for the expression of cytokines, such as pro-IL-1β and pro-IL-18, and following influenza virus infection, the inflammasome activation leads to homing of immune cells from the lung to the draining lymph nodes for activating cell-mediated immune responses [11]. In this study, we observed vast differences in the expression of mRNA of cytokines IL-6, IL-2, and IL-4 in the TBLN and MLN of piglets colonized with RIFM and UIFM, suggesting the likely role played by the diverse microbial groups. In one study, some members of nose/throat microbiota were found to be associated with susceptibility to influenza virus infection, but it is transitory among young children and stable among adults, suggesting the upper respiratory tract microbiota may be a potential target for reducing the burden of influenza viruses [47]. Significant correlations were observed between cytokine gene expression levels and relative abundances of several bacteria in trachea of influenza-infected turkeys. For example, IFNγ/λ and IL-6 gene expression levels were correlated positively with Staphylococcus and Pseudomonas abundance, and negatively correlated with abundance of Lactobacillus [48].
A systematic review revealed the positive role played by probiotics on immunity to influenza vaccines in human clinical trials through significantly improving hemagglutination inhibition antibody titers [49, 50]. The gut microbiota signals to the lung stromal cells keep the latter in an IFN-primed state, resulting in protection from influenza virus infection [51]. A probiotic strain of L. paracasei reduces the susceptibility to influenza infection by reducing inflammatory cell infiltrates in the lungs and promoting viral clearance [52]. In the lungs and MLN of piglets, we found modulation in the IFNγ gene expression influenced more by UIFM than RIFM. Overall, the expression of cytokines and pro-and anti-inflammatory responses to acute respiratory viral infection is potentially influenced by colonized diverse infant gut microbiota.
Immune cells and molecules present in mucosal tissues of the respiratory and intestinal tracts are connected throughout the body [53]. Thus, bilateral interactions of intestinal microbiota and its metabolites should influence, as well as be influenced by, the course of influenza virus infection [43]. The H7N9 influenza virus infection in people reduces intestinal microbiota diversity and increases colonization by E. coli and Enterococcus faecium [54]. Type I IFNs circulate via the bloodstream from the respiratory tract to the gut during influenza infection, and high levels of type I IFNs trigger IL-17 production leading to the production of several proinflammatory cytokines and chemokines [43]. These sequential events may allow opportunistic microorganisms to gain a foothold and even thrive in mucosal tissues [43].
The relative abundance of the detected bacterial phyla did not change in response to the viral infection two days post-infection, but at 4 and 7 days post-viral infection, Proteobacteria nearly diminished in both piglet groups. This contradicts a previous study that reported increased Proteobacteria in response to influenza virus infection in an influenza mouse model [55]. Mouse and humans differ in their gut microbiota [56], and we humanized the Gn piglet gut with infant fecal microbiota. It is plausible that gut microbiota can respond to influenza virus infection in a gut microbiota-dependent manner. Interestingly, Bacteroidetes filled the void left by Proteobacteria in the rural group, whereas Firmicutes occupied the niche left by Proteobacteria in the urban group. Although this study lacks a control group that was not infected with the influenza virus, the significant shifts at the phylum level within several days of the viral infection suggest that influenza virus infection can affect fecal microbiota. Further, the differences in phylum-level shifts between the two piglet groups also suggest that the influenza virus infection can impact the gut microbiota in a gut microbiota-dependent manner. This axiom, however, needs to be verified with phylum-specific qPCR.
Very little is known about how gut microbiota responds to influenza virus infection, but the observed increase in Klebsiella, whose members have polysaccharide-based capsules and colonize the nasal, oral, and intestinal tracts, concurs with a recent study that reported Klebsiella increase following influenza virus infection in piglets whose gut microbiota was humanized with fecal microbiota from healthy or obese donors [57]. Clostridium, Klebsiella, and Streptococcus all contain infectious species. Influenza virus infection increased Salmonella colonization in the gut of mice [55]. We thus interpret the increase of these genera to potentially represent an increased risk of gut infection by species of these genera, especially Clostridium, upon influenza infection.
A growing number of studies indicated that the microbiota colonizing the upper respiratory tract consisting of a high abundance of Streptococcus, Neisseria, and Haemophilus and a low abundance of Moraxella, Staphylococcus, Corynebacterium, and Dolosigranulum in healthy children following influenza A virus infection [3]. In another study, Streptococcus was significantly decreased in the nasopharynx following influenza virus infection, and decision tree analysis indicated that Ralstonia and Acidobacteria could discriminate microbial samples in healthy and influenza-infected animals with high accuracy [58].
Although some of the genera are commensal bacteria and correlation does not imply any causality, the correlations between the genera that contain infectious species or strains and expression of cytokines and immune cell counts are of potential clinical interest. These include the correlation between cytokine gene expression with Dosea, Dokdonella, Ochrobactrum, Enterococcus, Klebsiella, Streptococcus, Shigella, and Staphylococcus of bronchoalveolar lavage fluid. Also interestingly, some genera were correlated with both cytokine gene expression, immune cell counts, and immunoglobins abundance. Notably for bronchoalveolar lavage fluid microbiota, the relative abundance of the genera Sediminibacterium, Bosea, and Mesorhizobium was positively correlated with both TBLN IL-4 expression and BAL cells myeloid cell counts. On the contrary, the relative abundance of Bifidobacterium was negatively correlated with TBLN IL-4 expression and BAL cells myeloid cell counts. In addition, the relative abundance of the genus Klebsiella was negatively correlated with both TBLN IL-4 expression and TBLN cytotoxic T cells population. The genus of Alistipes was negatively correlated with both spleen and lung IFNγ production. Similarly, for the fecal microbiota, the genus of Parabacteroides was positively correlated with both the MLN IFNγ expression and the abundance of myeloid cells and non-T cells. However, for the colon microbiota, none of these genera was found to correlate with both cytokine expression and immune cells or immunoglobins abundance. Future research is needed to determine whether these bacterial genera play any significant role in regulating the immune response to influenza virus infection. Further studies should also focus on revealing the long-term impact of colonization of human microbes in a Gn piglet model on their stability, structure, and metabolites after influenza virus infection.
Data Availability
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request. The sequences reported in this paper have been deposited in NCBI with accession number: PRJNA1012342.
References
Thompson WW, Weintraub E, Dhankhar P, Cheng PY, Brammer L, Meltzer MI, Bresee JS, Shay DK (2009) Estimates of US influenza-associated deaths made using four different methods. Influenza Other Respir Viruses 3(1):37–49. https://doi.org/10.1111/j.1750-2659.2009.00073.x
Sakleshpur S, Steed AL (2022) Influenza: Toward understanding the immune response in the young. Front Pediatr 10:953150. https://doi.org/10.3389/fped.2022.953150
Wen Z, Xie G, Zhou Q, Qiu C, Li J, Hu Q, Dai W, Li D, Zheng Y, Wen F (2018) Distinct nasopharyngeal and oropharyngeal microbiota of children with influenza A virus compared with healthy children. Biomed Res Int 2018:6362716. https://doi.org/10.1155/2018/6362716
Wang B, Yao M, Lv L, Ling Z, Li L (2017) The Human microbiota in health and disease. Engineering 3(1):71–82. https://doi.org/10.1016/J.ENG.2017.01.008
Reynolds LA, Finlay BB (2017) Early life factors that affect allergy development. Nat Rev Immunol 17(8):518–528. https://doi.org/10.1038/nri.2017.39
Round JL, Mazmanian SK (2009) The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9(5):313–323. https://doi.org/10.1038/nri2515
Yassine HM, Lee CW, Gourapura R, Saif YM (2010) Interspecies and intraspecies transmission of influenza A viruses: viral, host and environmental factors. Anim Health Res Rev 11(1):53–72
Uchiyama J, Murakami H, Sato R, Mizukami K, Suzuki T, Shima A, Ishihara G, Sogawa K, Sakaguchi M (2020) Examination of the fecal microbiota in dairy cows infected with bovine leukemia virus. Vet Microbiol 240:108547. https://doi.org/10.1016/j.vetmic.2019.108547
Renu S, Renukaradhya GJ (2020) Chitosan nanoparticle based mucosal vaccines delivered against infectious diseases of poultry and pigs. Front Bioeng Biotechnol 8:558349. https://doi.org/10.3389/fbioe.2020.558349
Paules CI, Sullivan SG, Subbarao K, Fauci AS (2018) Chasing seasonal influenza - the need for a universal influenza vaccine. N Engl J Med 378(1):7–9. https://doi.org/10.1056/NEJMp1714916
Ichinohe T, Pang IK, Kumamoto Y, Peaper DR, Ho JH, Murray TS, Iwasaki A (2011) Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc Natl Acad Sci U S A 108(13):5354–5359. https://doi.org/10.1073/pnas.1019378108
Zhang Q, Hu J, Feng JW, Hu XT, Wang T, Gong WX, Huang K, Guo YX, Zou Z, Lin X, Zhou R, Yuan YQ, Zhang AD, Wei H, Cao G, Liu C, Chen LL, Jin ML (2020) Influenza infection elicits an expansion of gut population of endogenous bifidobacterium animalis which protects mice against infection. Genome Biol 21(1):99. https://doi.org/10.1186/s13059-020-02007-1
Lee KH, Foxman B, Kuan G, Lopez R, Shedden K, Ng S, Balmaseda A, Gordon A (2019) The respiratory microbiota: associations with influenza symptomatology and viral shedding. Ann Epidemiol 37(51–56):e56. https://doi.org/10.1016/j.annepidem.2019.07.013
Guinane CM, Cotter PD (2013) Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therap Adv Gastroenterol 6(4):295–308. https://doi.org/10.1177/1756283X13482996
Sekirov I, Tam NM, Jogova M, Robertson ML, Li Y, Lupp C, Finlay BB (2008) Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect Immun 76(10):4726–4736. https://doi.org/10.1128/IAI.00319-08
Gerritsen J, Smidt H, Rijkers GT, de Vos WM (2011) Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr 6(3):209–240. https://doi.org/10.1007/s12263-011-0229-7
Stein MM, Hrusch CL, Gozdz J, Igartua C, Pivniouk V, Murray SE, Ledford JG, Marques Dos Santos M, Anderson RL, Metwali N, Neilson JW, Maier RM, Gilbert JA, Holbreich M, Thorne PS, Martinez FD, von Mutius E, Vercelli D, Ober C, Sperling AI (2016) Innate immunity and asthma risk in amish and hutterite farm children. N Engl J Med 375(5):411–421. https://doi.org/10.1056/NEJMoa1508749
Nguyen TLA, Vieira-Silva S, Liston A, Raes J (2015) How informative is the mouse for human gut microbiota research? Dis Model Mech 8(1):1–16. https://doi.org/10.1242/dmm.017400
Arrieta MC, Walter J, Finlay BB (2016) Human microbiota-associated mice: a model with challenges. Cell Host Microbe 19(5):575–578
Chung H, Pamp SJ, Hill JA, Surana NK, Edelman SM, Troy EB, Reading NC, Villablanca EJ, Wang S, Mora JR, Umesaki Y, Mathis D, Benoist C, Relman DA, Kasper DL (2012) Gut immune maturation depends on colonization with a host-specific microbiota. Cell 149(7):1578–1593
Dhakal S, Wang L, Antony L, Rank J, Bernardo P, Ghimire S, Bondra K, Siems C, Lakshmanappa YS, Renu S, Hogshead B, Krakowka S, Kauffman M, Scaria J, LeJeune JT, Yu Z, Renukaradhya GJ (2019) Amish (Rural) vs. non-amish (Urban) infant fecal microbiotas are highly diverse and their transplantation lead to differences in mucosal immune maturation in a humanized germfree piglet model. Front Immunol. https://doi.org/10.3389/fimmu.2019.01509
Wang M, Donovan SM (2015) Human microbiota-associated swine: current progress and future opportunities. ILAR J 56(1):63–73. https://doi.org/10.1093/ilar/ilv006
Meurens F, Summerfield A, Nauwynck H, Saif L, Gerdts V (2012) The pig: a model for human infectious diseases. Trends Microbiol 20(1):50–57. https://doi.org/10.1016/j.tim.2011.11.002
Dawson HD, Smith AD, Chen C, Urban JF (2017) An in-depth comparison of the porcine, murine and human inflammasomes; lessons from the porcine genome and transcriptome. Vet Microbiol 202:2–15. https://doi.org/10.1016/j.vetmic.2016.05.013
Xia Q, Williams T, Hustead D, Price P, Morrison M, Yu Z (2012) Quantitative analysis of intestinal bacterial populations from term infants fed formula supplemented with fructo-oligosaccharides. J Pediatr Gastroenterol Nutr 55(3):314–320. https://doi.org/10.1097/MPG.0b013e3182523254
Williams TA, Yu Z (2009) A DNA-based investigation of intestinal microbiota of infants and the impact of prebiotics and maternal intestinal microbiota. PhD Thesis (The Ohio State University, Columbus, Ohio, USA)
Yuan L, Ward LA, Rosen BI, To TL, Saif LJ (1996) Systematic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease. J Virol 70(5):3075–3083
Renu S, Feliciano-Ruiz N, Lu F, Ghimire S, Han Y, Schrock J, Dhakal S, Patil V, Krakowka S, HogenEsch H, Renukaradhya GJ (2020) A nanoparticle-poly (I:C) combination adjuvant enhances the breadth of the immune response to inactivated influenza virus vaccine in pigs. Vaccines 8(2):229
Dhakal S, Hiremath J, Bondra K, Lakshmanappa YS, Shyu DL, Ouyang K, Kang KI, Binjawadagi B, Goodman J, Tabynov K, Krakowka S, Narasimhan B, Lee CW, Renukaradhya GJ (2017) Biodegradable nanoparticle delivery of inactivated swine influenza virus vaccine provides heterologous cell-mediated immune response in pigs. J Control Release 247:194–205. https://doi.org/10.1016/j.jconrel.2016.12.039
Dhakal S, Renu S, Ghimire S, Shaan Lakshmanappa Y, Hogshead BT, Feliciano-Ruiz N, Lu F, HogenEsch H, Krakowka S, Lee CW, Renukaradhya GJ (2018) Mucosal immunity and protective efficacy of intranasal inactivated influenza vaccine is improved by chitosan nanoparticle delivery in pigs. Front Immunol 9:934. https://doi.org/10.3389/fimmu.2018.00934
Patil V, Hernandez-Franco JF, Yadagiri G, Bugybayeva D, Dolatyabi S, Feliciano-Ruiz N, Schrock J, Hanson J, Ngunjiri J, HogenEsch H, Renukaradhya GJ (2022) A split influenza vaccine formulated with a combination adjuvant composed of alpha-D-glucan nanoparticles and a STING agonist elicits cross-protective immunity in pigs. J Nanobiotechnology 20(1):477. https://doi.org/10.1186/s12951-022-01677-2
Renu S, Markazi AD, Dhakal S, Lakshmanappa YS, Gourapura SR, Shanmugasundaram R, Senapati S, Narasimhan B, Selvaraj RK, Renukaradhya GJ (2018) Surface engineered polyanhydride-based oral salmonella subunit nanovaccine for poultry. Int J Nanomedicine 13:8195–8215. https://doi.org/10.2147/IJN.S185588
Lee CW, Suarez DL (2004) Application of real-time RT-PCR for the quantitation and competitive replication study of H5 and H7 subtype avian influenza virus. J Virol Methods 119(2):151–158. https://doi.org/10.1016/j.jviromet.2004.03.014
Renu S, Feliciano-Ruiz N, Patil V, Schrock J, Han Y, Ramesh A, Dhakal S, Hanson J, Krakowka S, Renukaradhya GJ (2021) Immunity and Protective Efficacy of Mannose Conjugated Chitosan-Based Influenza Nanovaccine in Maternal Antibody Positive Pigs. Front Immunol 12:584299. https://doi.org/10.3389/fimmu.2021.584299
Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, Alexander H, Alm EJ, Arumugam M, Asnicar F, Bai Y, Bisanz JE, Bittinger K, Brejnrod A, Brislawn CJ, Brown CT, Callahan BJ, Caraballo-Rodriguez AM, Chase J, Cope EK, Da Silva R, Diener C, Dorrestein PC, Douglas GM, Durall DM, Duvallet C, Edwardson CF, Ernst M, Estaki M, Fouquier J, Gauglitz JM, Gibbons SM, Gibson DL, Gonzalez A, Gorlick K, Guo J, Hillmann B, Holmes S, Holste H, Huttenhower C, Huttley GA, Janssen S, Jarmusch AK, Jiang L, Kaehler BD, Kang KB, Keefe CR, Keim P, Kelley ST, Knights D, Koester I, Kosciolek T, Kreps J, Langille MGI, Lee J, Ley R, Liu YX, Loftfield E, Lozupone C, Maher M, Marotz C, Martin BD, McDonald D, McIver LJ, Melnik AV, Metcalf JL, Morgan SC, Morton JT, Naimey AT, Navas-Molina JA, Nothias LF, Orchanian SB, Pearson T, Peoples SL, Petras D, Preuss ML, Pruesse E, Rasmussen LB, Rivers A, Robeson MS 2nd, Rosenthal P, Segata N, Shaffer M, Shiffer A, Sinha R, Song SJ, Spear JR, Swafford AD, Thompson LR, Torres PJ, Trinh P, Tripathi A, Turnbaugh PJ, Ul-Hasan S, van der Hooft JJJ, Vargas F, Vazquez-Baeza Y, Vogtmann E, von Hippel M, Walters W, Wan Y, Wang M, Warren J, Weber KC, Williamson CHD, Willis AD, Xu ZZ, Zaneveld JR, Zhang Y, Zhu Q, Knight R, Caporaso JG (2019) Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol 37(8):852–857. https://doi.org/10.1038/s41587-019-0209-9
Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP (2016) DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods 13(7):581–583
Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, Peplies J, Glöckner FO (2012) The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res 41(D1):D590–D596
McMurdie PJ, Holmes S (2013) phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE 8(4):e61217
R Core Team R (2018) R: A language and environment for statistical computing. In. R foundation for statistical computing Vienna, Austria
Oksanen J, Kindt R, Legendre P, O’Hara B, Stevens MHH, Oksanen MJ, Suggests M (2007) The vegan package Community ecology package. R package version 10(631–637):719
Gu Z, Eils R, Schlesner M (2016) Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32(18):2847–2849
Dwivedi V, Manickam C, Dhakal S, Binjawadagi B, Ouyang K, Hiremath J, Khatri M, Hague JG, Lee CW, Renukaradhya GJ (2016) Adjuvant effects of invariant NKT cell ligand potentiates the innate and adaptive immunity to an inactivated H1N1 swine influenza virus vaccine in pigs. Vet Microbiol 186:157–163. https://doi.org/10.1016/j.vetmic.2016.02.028
Chen CJ, Wu GH, Kuo RL, Shih SR (2017) Role of the intestinal microbiota in the immunomodulation of influenza virus infection. Microbes Infect 19(12):570–579. https://doi.org/10.1016/j.micinf.2017.09.002
Jeong HJ, Song YJ, Lee SW, Lee JB, Park SY, Song CS, Ha GW, Oh JS, Oh YK, Choi IS (2010) Comparative measurement of cell-mediated immune responses of swine to the M and N proteins of porcine reproductive and respiratory syndrome virus. Clin Vaccine Immunol 17(4):503–512. https://doi.org/10.1128/CVI.00365-09
Facci MR, Auray G, Buchanan R, van Kessel J, Thompson DR, Mackenzie-Dyck S, Babiuk LA, Gerdts V (2010) A comparison between isolated blood dendritic cells and monocyte-derived dendritic cells in pigs. Immunology 129(3):396–405. https://doi.org/10.1111/j.1365-2567.2009.03192.x
Harper A, Vijayakumar V, Ouwehand AC, Ter Haar J, Obis D, Espadaler J, Binda S, Desiraju S, Day R (2020) Viral Infections, the Microbiome, and Probiotics. Front Cell Infect Microbiol 10:596166. https://doi.org/10.3389/fcimb.2020.596166
Lee KH, Gordon A, Shedden K, Kuan G, Ng S, Balmaseda A, Foxman B (2019) The respiratory microbiome and susceptibility to influenza virus infection. PLoS ONE 14(1):e0207898. https://doi.org/10.1371/journal.pone.0207898
Ngunjiri JM, Taylor KJM, Ji H, Abundo MC, Ghorbani A, Kc M, Lee CW (2021) Influenza A virus infection in turkeys induces respiratory and enteric bacterial dysbiosis correlating with cytokine gene expression. PeerJ 9:e11806. https://doi.org/10.7717/peerj.11806
Yeh TL, Shih PC, Liu SJ, Lin CH, Liu JM, Lei WT, Lin CY (2018) The influence of prebiotic or probiotic supplementation on antibody titers after influenza vaccination: a systematic review and meta-analysis of randomized controlled trials. Drug Des Devel Ther 12:217–230. https://doi.org/10.2147/DDDT.S155110
Zimmermann P, Curtis N (2018) The influence of probiotics on vaccine responses - A systematic review. Vaccine 36(2):207–213. https://doi.org/10.1016/j.vaccine.2017.08.069
Bradley KC, Finsterbusch K, Schnepf D, Crotta S, Llorian M, Davidson S, Fuchs SY, Staeheli P, Wack A (2019) Microbiota-driven tonic interferon signals in lung stromal cells protect from influenza virus infection. Cell Rep 28(1):245–256
Belkacem N, Serafini N, Wheeler R, Derrien M, Boucinha L, Couesnon A, Cerf-Bensussan N, Gomperts Boneca I, Di Santo JP, Taha MK, Bourdet-Sicard R (2017) Lactobacillus paracasei feeding improves immune control of influenza infection in mice. PLoS ONE 12(9):e0184976. https://doi.org/10.1371/journal.pone.0184976
Wang J, Li F, Wei H, Lian ZX, Sun R, Tian Z (2014) Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation. J Exp Med 211(12):2397–2410. https://doi.org/10.1084/jem.20140625
Qin N, Zheng B, Yao J, Guo L, Zuo J, Wu L, Zhou J, Liu L, Guo J, Ni S, Li A, Zhu Y, Liang W, Xiao Y, Ehrlich SD, Li L (2015) Influence of H7N9 virus infection and associated treatment on human gut microbiota. Sci Rep 5:14771. https://doi.org/10.1038/srep14771
Deriu E, Boxx GM, He X, Pan C, Benavidez SD, Cen L, Rozengurt N, Shi W, Cheng G (2016) Influenza virus affects intestinal microbiota and secondary salmonella infection in the gut through type I interferons. Plos Pathog 12(5):e1005572. https://doi.org/10.1371/journal.ppat.1005572
Nagpal R, Wang S, Solberg Woods LC, Seshie O, Chung ST, Shively CA, Register TC, Craft S, McClain DA, Yadav H (2018) Comparative microbiome signatures and short-chain fatty acids in mouse, rat, non-human primate, and human feces. Front Microbiol 9:2897. https://doi.org/10.3389/fmicb.2018.02897
Renu S, Deblais L, Patil V, Schrock J, Kathayat D, Srivastava V, Feliciano-Ruiz N, Han Y, Ramesh A, Lakshmanappa YS (2022) Gut microbiota of obese children influences inflammatory mucosal immune pathways in the respiratory tract to influenza virus infection: optimization of an ideal duration of microbial colonization in a gnotobiotic pig model. Microbiology Spectrum 10:e02674-02621
Zhou Q, Xie G, Liu Y, Wang H, Yang Y, Shen K, Dai W, Li S, Zheng Y (2020) Different nasopharynx and oropharynx microbiota imbalance in children with Mycoplasma pneumoniae or influenza virus infection. Microb Pathog 144:104189. https://doi.org/10.1016/j.micpath.2020.104189
Acknowledgements
We would like to thank Jeff Ogg and the CFAH animal care crew for their help in pig studies.
Funding
This work was supported by the startup funds of GJR, and the salaries and research support were provided by state and federal funds appropriated to CFAES, The Ohio State University.
Author information
Authors and Affiliations
Contributions
JS, MY, ZY, and GJR conceived and developed the research, performed the experiments, analyzed the data, and wrote the manuscript. JS, SD, VP, GY, SR, AR, RW, JH, and GJR performed the animal and immunology experiments. All authors read and agreed to the content of the manuscript for publication.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethical Approval
The procedure for collection of infant fecal samples was approved by the Institutional Review Board of The Ohio State University. Piglet inoculation was carried out according to the recommendations of Public Health Service Policy, United States Department of Agriculture Regulations, the National Research Council’s Guide for the Care and Use of Laboratory Animals, and the Federation of Animal Science Societies’ Guide for the Care and Use of Agricultural Animals in Agricultural Research and Teaching. This study was performed in strict accordance with the recommendations put forth by the Public Health Service Policy, USDA Regulations, National Research Council’s Guide for the Care and Use of Laboratory Animals and the Federation of Animal Science Societies’ Guide for the Care and Use of Agricultural Animals in Agricultural Research and Teaching. All the pigs were maintained, samples collected and then euthanized, and all efforts were made to minimize the suffering of pigs as per the approved institutional, state, and federal regulations and policies regarding animal care and use at The Ohio State University on the Ethics for Animal Experiments (Protocol Number: 2019A00000068-R1).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Schrock, J., Yan, M., Dolatyabi, S. et al. Human Infant Fecal Microbiota Differentially Influences the Mucosal Immune Pathways Upon Influenza Infection in a Humanized Gnotobiotic Pig Model. Curr Microbiol 81, 267 (2024). https://doi.org/10.1007/s00284-024-03785-8
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00284-024-03785-8